AI assistant
Sending…
GENTEX CORP — Director's Dealing 2022
Nov 1, 2022
30893_dirs_2022-11-01_00648bd5-84b0-4411-99e1-a829300bde9b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2022-10-31
Reporting Person: Wallace James H (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-10-31 | Common Stock | S | 14000.00 | $26.0391 | Disposed | 14709.00 | Direct |
| 2022-10-31 | Common Stock | M | 7000.00 | $18.70 | Acquired | 21709.00 | Direct |
| 2022-10-31 | Common Stock | M | 7000.00 | $24.21 | Acquired | 28709.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-10-31 | Non-Employee Director Stock Option Grant | $24.21 | M | 7000.00 | Disposed | 2028-05-17 | Common Stock (7000.00) | Direct |
| 2022-10-31 | Non-Employee Director Stock Option Grant | $18.70 | M | 7000.00 | Disposed | 2027-05-18 | Common Stock (7000.00) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $25.89 to $26.135. The price reported above reflects the weighted average price.
More from GENTEX CORP
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19